Synergy Shield Coronary Stent 2.50 X 8 | REF H7493966608250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 8 mm (REF H7493966608250) for B2B medical device procurement.
The Medtronic Resolute Integrity Coronary Stent (REF RSINT30026X) is a zotarolimus-eluting coronary stent system in a 3.00 mm × 26 mm size, designed for percutaneous delivery during coronary interventions. It combines a Continuous Sinusoid Technology (CST) cobalt alloy stent platform with the BioLinx polymer and zotarolimus drug coating used across the Resolute platform.
Key Features
- Stent diameter: 3.00 mm
- Stent length: 26 mm
- Stent platform: Cobalt alloy with Continuous Sinusoid Technology (single-wire) construction
- Drug coating: Zotarolimus eluted from the BioLinx polymer system
- Delivery system: Rapid exchange (Rx) balloon catheter, 0.014 in guidewire compatible
- Guide catheter compatibility: Not specified in the located sources
- Sterility: Supplied sterile, single use
Clinical Applications
- Intended for use as a drug-eluting coronary stent in interventional cardiology procedures
- Designed to support vessel patency following balloon angioplasty in eligible coronary lesions
- Sized for mid-caliber coronary vessels requiring longer lesion coverage
- Specific indications, contraindications and patient selection criteria: refer to the manufacturer Instructions for Use
Product Information
- Brand: Medtronic
- Product line: Resolute Integrity
- Category: Coronary Stents
- REF / UPN: RSINT30026X
- Configuration: 3.00 mm × 26 mm drug-eluting stent on rapid exchange delivery system
- Packaging: Single-use sterile unit; confirm carton quantity with distributor
- Regulatory status and market availability: Not specified in the located sources; verify with Medtronic or authorized distributor prior to procurement
REF / UPNRSINT30026X
Size26 mm
Medtronic Resolute IntegrityResolute Integrity stentcoronary stent 3.0 x 26 mmzotarolimus eluting stentdrug eluting stentRSINT30026XMedtronic coronary stentDES coronary stentBioLinx polymer stentcobalt alloy coronary stentrapid exchange stent systeminterventional cardiology stentPCI drug eluting stentB2B medical device procurementcoronary stent catalog
How It Works
1
Submit Your Request
Tell us what product you need and share a few details.
2
We Match You
We connect your request with the most relevant verified brands.
3
Receive Offers
Relevant supplier options can respond with availability, documentation context, and quote details.
Related Products
Related products
Synergy Shield Coronary Stent 2.75 X 8 | REF H7493966608270
Boston Scientific Synergy Shield Coronary Stent, 2.75 mm x 8 mm (REF H7493966608270), available for B2B medical device procurement.
Synergy Shield Coronary Stent 3.00 X 8 | REF H7493966608300
Boston Scientific Synergy Shield Coronary Stent (3.00 mm x 8 mm), REF H7493966608300, supplied for B2B procurement.
Synergy Shield Coronary Stent 3.50 X 8 | REF H7493966608350
Boston Scientific Synergy Shield Coronary Stent, 3.50 mm x 8 mm (REF H7493966608350) for B2B medical device procurement.
Synergy Shield Coronary Stent 4.00 X 8 | REF H7493966608400
Boston Scientific Synergy Shield Coronary Stent, 4.00 mm x 8 mm (REF H7493966608400) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.25 X 12 | REF H7493966612220
Boston Scientific Synergy Shield Coronary Stent, 2.25 mm x 12 mm (REF H7493966612220) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.50 X 12 | REF H7493966612250
Boston Scientific Synergy Shield Coronary Stent, 2.50 mm x 12 mm (REF H7493966612250) for B2B medical device procurement.
Synergy Shield Coronary Stent 2.75 X 12 | REF H7493966612270
Boston Scientific Synergy Shield Coronary Stent, 2.75 mm x 12 mm (REF H7493966612270) for B2B medical device procurement.
Synergy Shield Coronary Stent 3.00 X 12 | REF H7493966612300
Boston Scientific Synergy Shield Coronary Stent, 3.00 mm x 12 mm (REF H7493966612300) for B2B medical device procurement.
Synergy Shield Coronary Stent 3.50 X 12 | REF H7493966612350
Boston Scientific Synergy Shield Coronary Stent, 3.50 mm x 12 mm (REF H7493966612350) for B2B medical device procurement.
Synergy Shield Coronary Stent 4.00 X 12 | REF H7493966612400
Boston Scientific Synergy Shield Coronary Stent, 4.00 mm x 12 mm, REF H7493966612400, supplied for B2B procurement.
Synergy Shield Coronary Stent 4.50 X 12 | REF H7493966612450
Boston Scientific Synergy Shield Coronary Stent, 4.50 mm x 12 mm (REF H7493966612450) for B2B medical device procurement.
Synergy Shield Coronary Stent 5.00 X 12 | REF H7493966612500
Boston Scientific Synergy Shield Coronary Stent, 5.00 mm x 12 mm (REF H7493966612500), supplied for B2B medical device procurement.
Synergy Shield Coronary Stent 2.25 X 16 | REF H7493966616220
Boston Scientific Synergy Shield Coronary Stent, 2.25 mm x 16 mm (REF H7493966616220), supplied for B2B procurement.
Buyer support
Frequently asked questions about Resolute Integrity Coronary Stent 3.00 × 26 mm | REF RSINT30026X
Practical answers for procurement teams reviewing this product page.
Include the exact product family, brand preference, REF/UPN code when available, required quantity, destination country, expected delivery timing and documentation expectations.
Yes. If alternatives are acceptable, mention equivalent brands, compatible models, size ranges and any non-negotiable requirements.
Related products are connected through structured catalog data such as brand, category, product family and country assignment.
No. This page supports sourcing and RFQ organization. Buyers must verify regulatory status, clinical suitability and procurement compliance independently.
Specific codes reduce ambiguity and help supplier teams identify product availability, packaging details and documentation faster.
Yes. The workflow is designed for hospitals, clinics, distributors, wholesalers, importers and procurement departments.
Yes. Products can be connected to multiple countries in the admin panel, and buyers can specify destination details in the RFQ form.
The request is stored with contact and procurement details so the sourcing conversation can be reviewed and followed up clearly.